Bank Of New York Mellon Corp Abb Vie Inc. Transaction History
Bank Of New York Mellon Corp
- $541 Trillion
- Q4 2024
A detailed history of Bank Of New York Mellon Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 13,663,900 shares of ABBV stock, worth $2.6 Billion. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,663,900
Previous 17,065,573
19.93%
Holding current value
$2.6 Billion
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding ABBV
# of Institutions
3,958Shares Held
1.26BCall Options Held
16.9MPut Options Held
13M-
Vanguard Group Inc Valley Forge, PA172MShares$32.7 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$26 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$15 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.96 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.37 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $337B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...